/HYEX
HYEX Stock - Healthy Extracts Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$1.91+0.00%
+$0.00 (+0.00%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.35
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HYEX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.89 – $1.93
TARGET (TP)$2.20
STOP LOSS$1.76
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-1.22
52W High$4.25
52W Low$0.81
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.11M | $2.49M | $2.25M | $1.47M | $1.28M |
| Gross Profit | $1.91M | $1.62M | $1.37M | $695,078 | $-578,442 |
| Gross Margin | 61.4% | 65.2% | 60.9% | 47.4% | -45.3% |
| Operating Income | $-183,149 | $-2,243,843 | $-904,749 | $-1,889,177 | $-2,053,332 |
| Net Income | $-840,671 | $-2,472,931 | $-989,962 | $-2,039,575 | $-2,649,257 |
| Net Margin | -27.0% | -99.5% | -44.0% | -139.1% | -207.5% |
| EPS | $-0.28 | $-0.85 | $-0.35 | $-0.77 | $-1.34 |
Company Overview
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
HYEXBeat Rate
0%
Last 1 quarters
Avg Surprise
-1196.0%
EPS vs Estimate
Beats / Misses
0/1
Last 12 quarters
Latest EPS
$-0.13
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
-1196.0%
$-0.13vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | $-0.01 | $-0.13 | -1196.0% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | — | $0.02 | — | — |
Q2 2025 | May 13, 2025 | — | $-0.13 | — | — |
Q2 2025 | Apr 1, 2025 | — | $-0.15 | — | — |
Q4 2024 | Nov 12, 2024 | — | $0.12 | — | — |
Q3 2024 | Aug 14, 2024 | — | $0.04 | — | — |
Q2 2024 | May 17, 2024 | — | $-0.30 | — | — |
Q2 2024 | Apr 1, 2024 | — | $-0.13 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.09 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.44 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.20 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.02 | — | — |
Q4 2022 | Nov 8, 2022 | — | $-0.06 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.31 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.20 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.25 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.21 | — | — |
Q3 2021 | Aug 3, 2021 | — | $-0.50 | — | — |
Q3 2021 | Aug 3, 2021 | — | $-0.64 | — | — |
Latest News
Gelteq Technology Powers U.S. Launch Of Healthy Extracts' Nutraceuticals, Marking Transition From R&D To Commercialization
📈 PositiveBenzinga•Sep 12, 2025, 11:33 AM•Also:
Gelteq And Healthy Extracts Launch Hydrate EZ And Mynus Sugar Gel-Packs With Innovative No-Mix Delivery Technology
📈 PositiveBenzinga•Sep 4, 2025, 12:43 PM•Also:
Frequently Asked Questions about HYEX
What is HYEX's current stock price?
Healthy Extracts Inc. (HYEX) is currently trading at $1.91 per share. The stock has moved +0.00% today.
What is the analyst price target for HYEX?
No analyst price targets are currently available for this stock.
What sector is Healthy Extracts Inc. in?
Healthy Extracts Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is HYEX's market cap?
Healthy Extracts Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does HYEX pay dividends?
No, Healthy Extracts Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAUSAF
Australis Capital Inc.
$0.00
Mkt Cap: $0.0B
AYURF
Ayurcann Holdings Corp.
$0.01
Mkt Cap: $0.0B
BUDZ
WEED, Inc.
$0.07
Mkt Cap: $0.0B
CBIH
Cannabis Bioscience International Holdings, Inc.
$0.00
Mkt Cap: $0.0B
CRRTF
Crescita Therapeutics Inc.
$0.02
Mkt Cap: $0.0B
CVSI
CV Sciences, Inc.
$0.07
Mkt Cap: $0.0B
DHBUF
Delivra Health Brands Inc.
$0.18
Mkt Cap: $0.0B
IONKF
Ionic Brands Corp.
$0.00
Mkt Cap: $0.0B
LOBEF
Lobe Sciences Ltd.
$0.00
Mkt Cap: $0.0B
TWSI
Tristar Wellness Solutions Inc.
$0.17
Mkt Cap: $0.0B
Explore stocks similar to HYEX for comparison